MassResearch

What MassResearch does

MassResearch is an independent, single-site clinical research organization founded in 1992 and headquartered in Waltham, Massachusetts. The company provides protocol development and clinical testing services for pharmaceutical and medical device sponsors, conducting Phase I-IV inpatient and outpatient trials, pharmacokinetic and pharmacodynamic studies (including 24-hour glucose tolerance testing and clamp studies), medical device accuracy/robustness/user studies, medical focus groups, and protocol design support. It serves a mixed sponsor base of major pharmaceutical companies, CROs, medical device manufacturers, and startups, with over 80% of sponsors having worked with the company for more than 20 years.

The company's competitive positioning is built on a board-certified, multi-specialty investigator team affiliated with Harvard Medical School, Newton-Wellesley Hospital, Massachusetts General Hospital, and other New England institutions, supported by a 3,500+ patient database and access to investigators' private practices. The team covers endocrinology, cardiology, neurology, dermatology, urology, nephrology, pulmonology, podiatry, and ophthalmology, with diabetes and endocrinology remaining the historical core. Compliance is anchored by a 30-year track record, hundreds of passed sponsor audits, and a single FDA audit with no findings. The Discovery Series educational forum (launched 2018) and the MassResearch BioMedical sub-brand extend the company's reach into community engagement and dedicated biomedical services.

MassResearch operates as a professional services business under a private, bootstrapped ownership structure (MassResearch, LLC) with 11-50 employees. Revenue is generated through per-protocol and per-patient service fees under non-disclosed enterprise contracts, with participant stipends typically ranging from $500 to $3,000. The go-to-market is relationship-driven enterprise sales to sponsor organizations, supplemented by a passive top-of-funnel patient recruitment database and community education programming. No venture capital, private equity, or parent-company ownership is indicated, and the company has pursued no disclosed acquisitions, funding rounds, or geographic expansion beyond the New England market.

Name

MassResearch

Legal name

MassResearch, LLC

Website

https://massmedix.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

MassResearch is an independent, single-site clinical research organization in Waltham, MA, founded in 1992, conducting Phase I-IV pharmaceutical trials, pharmacokinetic studies, and medical device testing for pharma, device manufacturers, and startup sponsors across multiple therapeutic specialties.

Ownership category

akta.pro rank

Headquarters

HQ city

Maussane

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services: MassResearch generates revenue by developing protocols and conducting clinical studies for pharmaceutical companies and medical device manufacturers. Services include Phase I-IV inpatient and outpatient studies, pharmacokinetic studies, clamp studies, and medical device testing.
2. Medical Focus Groups: Conducting medical focus groups for packaging evaluation, package inserts, applications, opinions, design reviews, and professional focus groups involving MDs, RNs, Dietitians, and other healthcare professionals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

MassResearch is an independent clinical research organization that designs and executes Phase I–IV inpatient and outpatient clinical trials, pharmacokinetic and clamp studies, and FDA-aligned medical device accuracy, robustness, and user studies. It also runs medical focus groups and protocol design/development services for pharmaceutical sponsors, medical device manufacturers, and start-up companies across multiple therapeutic areas.

Product overview

MassResearch is an independent, multi-specialty medical research company that operates as a single unified clinical research service offering rather than a platform-plus-modules architecture. The company provides integrated clinical research services including clinical trials (Phase I-IV), PK & PD studies, pharmacokinetic and clamp studies, medical device testing (blood glucose meters, robustness testing, wearables, transdermal delivery), medical focus groups, and protocol design and development. The portfolio is unified under the MassResearch brand, with supporting educational programming through the Discovery Series forum. The core offering centers on unbiased investigation of medications, treatments, and medical devices for pharmaceutical and device company sponsors.

Differentiator

Problem solved

Functional benefit

Brands

• MassResearch BioMedical: Biomedical division mentioned in the Discovery Series program as a sponsor for educational events.

Products and services

• Clinical Trials (Phase I–IV) Phase I–IV inpatient and outpatient clinical studies covering pharmacokinetic, clamp, and various therapeutic areas with healthy patient studies, delivered for pharmaceutical sponsors.
• PK & PD Studies Pharmacokinetic and pharmacodynamic studies including 24-hour glucose tolerance testing and clamp studies for pharmaceutical sponsors.
• Medical Device Testing Blood glucose meter accuracy and robustness testing, lancets, injectors, applications, wearables, transdermal delivery, and medication patch testing using FDA requirements, delivered for medical device manufacturers.
• Medical Focus Groups Evaluation of packaging, package inserts, applications, opinion research, and design assessment for medical devices, serving MD, RN, Dietitian, LD, Nutritionist, CDE, and other professional groups.
• Protocol Design and Development Protocol development services for pharmaceutical and medical device companies, including assistance for start-ups in the investigational and approval process.
• Device Design and Testing Medical device design assistance and testing services following FDA requirements for accuracy, robustness, and user studies.
• Electronic Diaries Electronic diary systems used in clinical trials for patient-reported outcomes and data collection.

Quantifiable outcome

• Over 80% of sponsors have worked with MassResearch for more than 20 years
• +3 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• ICON plc: ICON plc is a top-tier global CRO offering clinical development, biometrics, and laboratory services across all phases and therapeutic areas. Comparable in core service offering (Phase I-IV trials, device studies) but operates at global scale with thousands of employees versus MassResearch's single-site, sub-50-employee operation.
• Syneos Health: Syneos Health is a global CRO (now taken private) providing Phase I-IV clinical development alongside commercial services. Comparable in core Phase I-IV and medical device clinical research offerings but at global scale, serving many of the same enterprise pharma sponsors as MassResearch.
• Charles River Laboratories: Charles River Laboratories provides CRO/CDMO services spanning preclinical through clinical research, including early-stage clinical trials. Overlaps with MassResearch in Phase I clinical execution and medical device testing, but operates at massive global scale with integrated discovery-to-clinical capabilities.
• IQVIA: IQVIA is the largest global CRO, providing Phase I-IV clinical research, real-world evidence, and consulting across all therapeutic areas. It is the dominant incumbent that sponsors choose when scale, global reach, and integrated data analytics are required — directly competing with MassResearch for enterprise sponsor work but at a vastly larger scale.
• Fortrea: Fortrea (spun off from Labcorp in 2023) is a major global CRO providing clinical development and clinical trial enabling services. Directly comparable in Phase I-IV and medical device clinical testing offerings but operates at vastly larger scale and serves the same enterprise pharma sponsors.
• Parexel: Parexel is a global CRO offering Phase I-IV clinical development, regulatory, and market access services. Comparable in core offering of pharmaceutical and medical device clinical testing, but at global scale and with broader service portfolio than MassResearch's site-based model.

Direct peers

• Medpace: Medpace is a mid-sized, scientifically-focused CRO providing full-service Phase I-IV clinical development with deep therapeutic expertise. It is the closest comparable to MassResearch in operating model (scientifically led, multi-specialty, full-service), though significantly larger and globally distributed.
• Rho: Rho is a privately-held, mid-size CRO offering clinical research services across multiple therapeutic areas with a scientifically-led model. Comparable to MassResearch in scale, independence, and full-service approach, serving similar pharma and device sponsors.
• Celerion: Celerion is a specialized early-phase clinical research CRO with strong capabilities in metabolic disease, PK/PD studies, and clamp studies — a direct service-line peer to MassResearch's pharmacokinetic, glucose clamp, and diabetes trial offerings. Comparable in scale and Phase I focus.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO with deep expertise in cardiometabolic, neuroscience, and rare disease trials — directly mirroring MassResearch's diabetes/endocrinology focus. Comparable in size and therapeutic emphasis, serving the same pharma sponsors for specialized Phase I-IV work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/MassResearch
• LinkedInlinkedin.com/company/massresearch-llc

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MassResearch